Edition:
India

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

101.20USD
1:32am IST
Change (% chg)

$1.30 (+1.30%)
Prev Close
$99.90
Open
$100.34
Day's High
$101.53
Day's Low
$100.34
Volume
64,286
Avg. Vol
90,899
52-wk High
$101.53
52-wk Low
$67.21

CRL.N

Chart for CRL.N

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $4,759.17
Shares Outstanding(Mil.): 47.64
Dividend: --
Yield (%): --

Financials

BRIEF-Spago Nanomedical signs deal with Charles River Laboratories for preclinical studies

* ANNOUNCE AGREEMENT WOTH CHARLES RIVER LABORATORIES FOR PRECLINICAL STUDIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

08 Jun 2017

BRIEF-Charles River Laboratories reports updates to oncology business

May 16 Charles River Laboratories International Inc:

16 May 2017

BRIEF-Charles River Laboratories reports Q1 non-GAAP earnings per share $1.29

May 10 Charles River Laboratories International Inc:

10 May 2017

BRIEF-Nimbus Therapeutics enters strategic partnership with Charles River Laboratories

April 5 Charles River Laboratories International Inc:

05 Apr 2017

BRIEF-Charles River Laboratories reports Q4 GAAP earnings per share $0.93

Feb 14 Charles River Laboratories International Inc

14 Feb 2017

More From Around the Web

Earnings vs. Estimates